Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Frontiers in Oncology
|
September 4, 2023
Dermatomyositis with intrahepatic cholangiocarcinoma: a case report and data mining based on machine learning
Xusheng Zhang, Bendong Chen
Molecules (Basel, Switzerland)
|
April 24, 2012
Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats
Bendong Chen, Mingliang Ning, Guangshun Yang
Medicine
|
January 7, 2026
Serum uric acid and the risk of MASLD in Americans: A cross-sectional study combined with Mendelian randomization and network toxicology analysis
Xusheng Zhang, Wenyan Zhou, Bendong Chen, et al.
Discover Oncology
|
July 1, 2025
Research trends and visualization analysis of autoimmune disease-related liver cancer from 2004 to 2024: a bibliometric study
Xusheng Zhang, Yannan Xie, Wenyan Zhou, et al.
Molecular Biology Reports
|
May 12, 2012
Effects of aqueous extract of Portulaca oleracea L. on oxidative stress and liver, spleen leptin, PARα and FAS mRNA expression in high-fat diet induced mice
Bendong Chen, Haining Zhou, Wenchao Zhao, et al.
Frontiers in Bioscience (Landmark Edition)
|
November 6, 2025
Study on the Mechanism of CCN2 Promoting Sorafenib Resistance in HCC and Its Combined Intervention Strategy
Lei Cui, Junhao Liu, Yongxue Lv, et al.
Discover Oncology
|
June 29, 2026
Aspartame drives the continuous progression from MASLD to HCC
Xusheng Zhang, Rong Tan, Yongxin Ma, et al.
Frontiers in Bioscience (Landmark Edition)
|
September 8, 2025
MED10 as a Novel Oncogenic Driver in HCC: Promoting Cell Cycle Progression and Proliferation Through RAF1 Activation
Junhao Liu, Yongxue Lv, Kejun Liu, et al.
Functional & Integrative Genomics
|
September 29, 2023
miR-429 inhibits the formation of an immunosuppressive microenvironment to counteract hepatocellular carcinoma immune escape by targeting PD-L1
Xuehai Yu, Xiongwei Fan, Xusheng Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 22, 2025
Single-Cell Multi-Omics Reveals B2M-Mediated Myeloid Reprogramming and Constructs a Predictive Model for Early Hepatocellular Carcinoma Recurrence
Zhenyao Tan, Yezhen Tang, Bendong Chen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Frontiers in Oncology
|
September 4, 2023
Dermatomyositis with intrahepatic cholangiocarcinoma: a case report and data mining based on machine learning
Xusheng Zhang, Bendong Chen
Molecules (Basel, Switzerland)
|
April 24, 2012
Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats
Bendong Chen, Mingliang Ning, Guangshun Yang
Medicine
|
January 7, 2026
Serum uric acid and the risk of MASLD in Americans: A cross-sectional study combined with Mendelian randomization and network toxicology analysis
Xusheng Zhang, Wenyan Zhou, Bendong Chen, et al.
Discover Oncology
|
July 1, 2025
Research trends and visualization analysis of autoimmune disease-related liver cancer from 2004 to 2024: a bibliometric study
Xusheng Zhang, Yannan Xie, Wenyan Zhou, et al.
Molecular Biology Reports
|
May 12, 2012
Effects of aqueous extract of Portulaca oleracea L. on oxidative stress and liver, spleen leptin, PARα and FAS mRNA expression in high-fat diet induced mice
Bendong Chen, Haining Zhou, Wenchao Zhao, et al.
Frontiers in Bioscience (Landmark Edition)
|
November 6, 2025
Study on the Mechanism of CCN2 Promoting Sorafenib Resistance in HCC and Its Combined Intervention Strategy
Lei Cui, Junhao Liu, Yongxue Lv, et al.
Discover Oncology
|
June 29, 2026
Aspartame drives the continuous progression from MASLD to HCC
Xusheng Zhang, Rong Tan, Yongxin Ma, et al.
Frontiers in Bioscience (Landmark Edition)
|
September 8, 2025
MED10 as a Novel Oncogenic Driver in HCC: Promoting Cell Cycle Progression and Proliferation Through RAF1 Activation
Junhao Liu, Yongxue Lv, Kejun Liu, et al.
Functional & Integrative Genomics
|
September 29, 2023
miR-429 inhibits the formation of an immunosuppressive microenvironment to counteract hepatocellular carcinoma immune escape by targeting PD-L1
Xuehai Yu, Xiongwei Fan, Xusheng Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 22, 2025
Single-Cell Multi-Omics Reveals B2M-Mediated Myeloid Reprogramming and Constructs a Predictive Model for Early Hepatocellular Carcinoma Recurrence
Zhenyao Tan, Yezhen Tang, Bendong Chen, et al.
Page
of 3